The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
But she also emphasized that GLP-1 medications such as Mounjaro and Ozempic are not the only options when it comes to weight loss or diabetes, and significantly more affordable FDA-approved ...
Ozempic is excellent for weight loss, but it’s expensive and requires a prescription. It has unwanted side effects like nausea and “Ozempic face.” After a clinical trial, the FDA approved ...